12:00 AM
Sep 13, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Results

CAT-152: Phase I/IIa data; Phase II

CAT's U.K. trial in 24 patients undergoing trabeculectomy showed that CAT-152 was well tolerated, with no serious local injection site reactions and no serious adverse...

Read the full 105 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >